Baylor College of Medicine, Houston, TX.
Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT.
Urol Oncol. 2020 Jan;38(1):23-30. doi: 10.1016/j.urolonc.2018.12.018. Epub 2019 Jan 2.
Recent advances in cancer research have highlighted the role of genetics in malignancy. Genetic dysregulation of core cellular functions similarly influences benign conditions. These common genetic factors have led researchers to identify an association between certain urologic conditions and malignancy. The objective of this review is to evaluate the literature linking benign urologic conditions including male infertility, Peyronie's disease, cryptorchidism, and hypospadias, to malignancy.
A search of PubMed was performed using the following search terms and their combinations: male infertility, female infertility, cancer, malignancy, mortality, male urologic conditions, azoospermia, Peyronie's disease, cryptorchidism, hypospadias, and genetics. Studies were assessed for quality and included or excluded based on study design and relevance to the topic of urologic conditions and malignancy.
A total of 52 studies were evaluated, of which 38 were included. Associations between male infertility and testicular cancer, prostate cancer, and other cancers including melanoma, bladder cancer, and thyroid cancer were examined. Several genetic alterations were found to be common in the pathogenesis of both male infertility and carcinogenesis. Associations between female infertility and breast, ovarian, and endometrial cancer are also assessed, as are the relationships between Peyronie's disease, cryptorchidism, and hypospadias and malignancy.
Recent work has identified associations between a number of malignancies and benign urologic conditions including male infertility, Peyronie's disease, cryptorchidism, and hypospadias. Molecular and genetic mechanisms have been proposed, but no definitive causal relationships have been identified to date. Future work will continue to better define the links between malignancy and benign urologic conditions and ultimately facilitate risk stratification, screening, and treatment of affected men.
癌症研究的最新进展强调了遗传学在恶性肿瘤中的作用。核心细胞功能的遗传失调同样会影响良性疾病。这些常见的遗传因素促使研究人员发现某些泌尿科疾病与恶性肿瘤之间存在关联。本综述的目的是评估将包括男性不育症、佩罗尼病、隐睾和尿道下裂在内的良性泌尿科疾病与恶性肿瘤联系起来的文献。
使用以下搜索词及其组合在 PubMed 上进行搜索:男性不育症、女性不育症、癌症、恶性肿瘤、死亡率、男性泌尿科疾病、无精子症、佩罗尼病、隐睾、尿道下裂和遗传学。根据研究设计和与泌尿科疾病和恶性肿瘤主题的相关性,评估研究的质量,并纳入或排除研究。
共评估了 52 项研究,其中 38 项研究被纳入。检查了男性不育症与睾丸癌、前列腺癌和其他癌症(包括黑色素瘤、膀胱癌和甲状腺癌)之间的关联。发现一些遗传改变在男性不育症和癌发生的发病机制中是共同的。还评估了女性不育症与乳腺癌、卵巢癌和子宫内膜癌之间的关系,以及佩罗尼病、隐睾和尿道下裂与恶性肿瘤之间的关系。
最近的研究已经确定了一些恶性肿瘤与良性泌尿科疾病之间的关联,包括男性不育症、佩罗尼病、隐睾和尿道下裂。已经提出了分子和遗传机制,但迄今为止尚未确定明确的因果关系。未来的工作将继续更好地定义恶性肿瘤与良性泌尿科疾病之间的联系,并最终促进受影响男性的风险分层、筛查和治疗。